Smart Pills Market Size & Share 2026-2035

Smart Pills Market Size

The global smart pills market was valued at USD 1.3 billion in 2025. The market size is estimated to grow from USD 1.4 billion in 2026 to USD 3.9 billion in 2035, growing at a CAGR of 11.8% over the analysis period, as per the latest report published by Global Market Insights Inc.

Smart pill technology is also benefiting from advancements in data analytics and artificial intelligence. AI improves data analytics capabilities, facilitating better and quicker diagnosis, accurate treatment, and preventive care approaches, making it easier for healthcare professionals. Further, the use of the Internet of Things (IoT) facilitates remote monitoring and enables doctors to monitor patients’ health parameters without the need for periodic visits to the hospital.
 

Smart pills are defined as an ingestible capsule containing electronic or mechanical elements that traverse the gastrointestinal (GI) tract for purposes ranging from diagnosis, treatment, and monitoring. These pills can be easily swallowed by patients, thereby resulting in minimal discomfort. Key players in this market include Medtronic, Olympus Corporation, CapsoVision, IntroMedic, and Check‑Cap. These companies are actively advancing smart pill technologies through continuous innovation in capsule endoscopy platforms, sensor integration, wireless data transmission, and AI-enabled image analysis, thereby strengthening product capabilities and expanding clinical adoption across gastrointestinal diagnostics and digital health monitoring applications.
 

A key contributor was the rising adoption of minimally invasive procedures by healthcare systems. With smart pills offering improved patient comfort, reduced complication risk, and faster recovery compared to conventional endoscopy, there was a rapid shift towards minimally invasive procedures. Rapid advancements in microelectronics, wireless communication, and sensor technologies further enhanced device capabilities, enabling real-time physiological monitoring and expanding clinical applications.
 

Smart Pills Market Trends

• Rising demand for non-invasive diagnostic techniques is anticipated to drive the market growth. Patients and healthcare professionals are seeking less invasive and more comfortable options for traditional endoscopy. Smart pills that contain tiny cameras and sensors allow for imaging without the discomfort of traditional endoscopy methods.
   
• These capsules move through the digestive tract, collecting data and images throughout the process. This is highly beneficial for diagnosing difficult cases of small intestine disorders. Thus, with growing awareness, smart pill devices are anticipated to witness high adoption in everyday diagnostic procedures.
   
• GI diseases and digestive disorders such as Crohn’s, colorectal cancer, and irritable bowel syndrome (IBS) are increasingly common because of lifestyle factors and older populations. For instance, as per the Johns Hopkins Hospital, inflammatory bowel disease affects as many as 1.6 million Americans, with most cases diagnosed before age 35. Further, GI cancers account for nearly 26% of the global cancer burden. The Cancer Statistics 2025 report projects that an estimated 107,320 cases of colon cancer and 46,950 cases of rectal cancer will be diagnosed in the U.S., and a total of 52,900 people will die from these cancers. Such a rising prevalence of GI disorders increases the demand for effective diagnostic and monitoring devices, thereby fueling the market growth.
   
• Growing investments from government agencies and private companies into cutting-edge innovations will drive the market growth. Market players such as CapsoVision and Medtronic are developing new products to enhance diagnostic effectiveness. The support from research institutions is also contributing to progress in the fields of wireless data transmission and ingestible sensors. Thus, with more financial support and funding, smart pills are anticipated to become more advanced, affordable, and accessible.
   
• Moreover, AI and machine learning technology are improving the effectiveness of the smart pill system. Smart pills equipped with artificial intelligence can scan and report data with incredible accuracy. AI technology also incorporates predictive analysis, enabling healthcare professionals to resolve health problems before they escalate. As AI technology continues to spread, smart pills will become increasingly important in aiding diagnosis and crafting treatment approaches, thereby fueling market growth.
   

Smart Pills Market Analysis

Based on the component, the smart pills market is segmented into product and patient monitoring software. The product segment is further divided into capsule and other products. The product segment dominated the market in 2025 and accounted for USD 802.8 million.
 

• Smart capsules contain sensors, microchips, and wireless communication systems that report real-time information regarding the gastrointestinal (GI) system, medication compliance, and disease progression.
   
• These devices are easy to swallow, non-invasive, and accurately deliver drug dosages; hence, they are preferred over traditional diagnostic and treatment procedures.
   
• Furthermore, the expansion of the use of smart capsules in the healthcare sector is due to increased adoption of biocompatible materials, sophisticated technologies for remote patient monitoring, and wearable sensor patches for monitoring vital signs.
   
• In addition, new technological developments and AI, coupled with IoT automation, increase the diagnostic and therapeutic functions of smart pills, deepening their market dominance.
   
• Thus, with advancements in technology and increasing acceptance of digital health solutions, the product segment is expected to continue dominating the market.
   

Based on the target area, the smart pills market is segmented into the stomach, small intestine, large intestine, and esophagus. The stomach segment dominated the market with 44% of the market share in 2025.
 

• This segment has a notable share of the market due to its use in the diagnosis and surveillance of stomach diseases. Smart pills designed for stomach applications include capsule endoscopes and drug delivery systems.
   
• These allow real-time, non-invasive assessment of conditions such as gastritis, gastric ulcers, and gastric cancer. The rising frequency of these disorders and the need for precise and timely diagnosis have increased the use of smart pills for stomach ailments.
   
• Further, the effectiveness of smart pill stomach devices has greatly increased due to improved sensor technology, imaging technology, and wireless communication, which have made them more popular among patients and physicians.
   
• These pills enhance patient comfort and minimize the need for sedation while also providing detailed visualization of the stomach lining, which makes them an attractive alternative to conventional methods.
   
• The small intestine segment held the second highest market share with a revenue of USD 343.4 million in 2025, primarily driven by the widespread use of capsule endoscopy for detecting small bowel bleeding, Crohn’s disease, tumors, and other obscure gastrointestinal conditions where conventional endoscopy has limited reach.
   

Based on the application, the smart pills market is categorized into capsule endoscopy, targeted drug delivery, and vital sign monitoring. The capsule endoscopy segment dominated the market and is predicted to grow at a CAGR of 11.6% over the forecast period.
 

• Capsule endoscopy dominates the market because of its non-invasive nature and superior diagnostic capabilities. The rising demand from patients and healthcare professionals for non-invasive diagnostic procedures has increased the adoption of smart pills for capsule endoscopy.
   
• Capsule endoscopy offers a comprehensive visualization of the entire digestive system, especially of the small bowel, which is difficult to reach through traditional endoscopic approaches.
   
• The increasing prevalence of Crohn’s disease, gastrointestinal bleeding, and small bowel tumors further boosts the market growth of capsule endoscopy.
   
• Moreover, the accuracy and efficiency of the devices have been heightened by improvements in imaging technologies, AI-based image processing, and longer-lasting batteries.
   
• Additionally, favorable reimbursement policies, growing awareness regarding early detection of diseases, and rapidly developing infrastructure in developed and developing countries are further helping to expand the market.
   
• The targeted drug delivery segment, on the other hand, is expected to witness strong growth at a CAGR of 12.3% over the forecast years, driven by increasing research into ingestible technologies capable of delivering therapeutics directly to specific regions of the gastrointestinal tract, thereby improving treatment efficacy, minimizing systemic side effects, and supporting the advancement of precision medicine approaches.
   

Based on the end use, the smart pills market is segmented into hospitals, diagnostic centers, and other end users. The hospitals segment held the highest market share in 2025 and is anticipated to reach USD 2.4 billion in 2035.
 

• Hospitals play a vital role in diagnosing and treating complicated health issues. As they are the primary providers of specialized diagnostic services, long-term disease management, and post-operative care, hospital settings adopt smart pills technology more readily than other types of facilities.
   
• Moreover, with the increasing prevalence of chronic diseases such as GI cancers, colorectal cancers, and Crohn's disease, hospitals have been increasingly adopting smart pills for more efficient monitoring and intervention.
   
• Hospitals also act as primary sites for clinical and research trials, which further facilitates the adoption of new technologies into routine healthcare.
   
• Further, due to high-quality infrastructure and the presence of high-quality treatment options coupled with the expertise of healthcare practitioners and favorable reimbursement policies, hospitals are anticipated to remain the principal end users in the market.
   

North America Smart Pills Market

North America market was valued at USD 503.5 million in 2025 and is anticipated to grow at a CAGR of 11.5% over the forecast years.
 

• Factors such as advanced healthcare facilities, robust healthcare infrastructure, and high adoption of modern medical technologies aid in high market growth.
   
• Furthermore, the increasing prevalence of gastrointestinal disorders and chronic diseases and the rising elderly population significantly boost the growth of smart pills.
   
• The presence of leading pharmaceutical and medical device companies, such as Medtronic, has led to innovation in the area of ingestible sensor and smart pills technology, further accelerating the market growth.
   
• Also, support from government bodies and investments by market players support market growth.
   

The U.S. dominated the North America smart pills industry with a revenue of USD 343.8 million and USD 379.1 million in 2022 and 2023, respectively. The market was valued at USD 462 million in 2025, growing from USD 418.3 million in 2024.
 

• The U.S. accounts for a high share of the North America market, primarily driven by advanced healthcare infrastructure, early adoption of minimally invasive diagnostic technologies, and the strong presence of leading smart pill manufacturers.
   
• High awareness among clinicians and patients, favorable reimbursement for capsule endoscopy procedures, and increasing prevalence of gastrointestinal disorders further support widespread utilization of ingestible diagnostic devices.
   
• Additionally, robust research activity, regulatory support for innovative digital health technologies, and integration of smart pills with remote monitoring platforms continue to reinforce the country’s leadership position in the market.
   

Europe Smart Pills Market

Europe market is anticipated to witness rapid growth at a CAGR of 12% over the forecast period.
 

• The region holds a significant market share in the smart pills industry due to its well-developed healthcare system, growth in the number of gastrointestinal disorders, and high adoption of modern medical technologies.
   
• For example, over 332 million people are estimated to be living with a digestive disorder in the European region, according to a report from United European Gastroenterology (UEG).
   
• Moreover, the expanding older population in Europe with a greater burden of chronic illnesses requiring regular supervision further enhances the need for smart pills.
   
• Further, the presence of top pharmaceutical and medical technology companies investing in smart pills R&D is propelling Europe's market share.
   
• Market growth is also fueled by rising patient and healthcare professional awareness regarding the advantages of ingestible sensors for health monitoring.
   

UK smart pills market is anticipated to witness robust growth in the Europe market.

• The presence of the leading pharmaceutical and medical device manufacturing companies and well-established research centers within the UK is aiding the fast-paced development and commercial use of these devices.
   
• Public funding for R&D, coupled with several initiatives by market players and health institutions, also optimizes the growth opportunities of the market.
   
• In addition, favorable reimbursement scenarios and rapid technological advancements in drug delivery systems are also driving the market's expansion.
   

Asia Pacific Smart Pills Market

Asia Pacific market was valued at USD 290 million in 2025.
 

• Increasing spending on healthcare, growing elderly population, and inclination towards digital health are fuelling the expansion of the smart pills industry in the Asia Pacific region.
   
• A high burden of chronic diseases such as GI cancer, Crohn's disease, ulcerative colitis, and stomach ulcers further boosts market growth.
   
• For example, studies suggest that approximately 50% of all new gastric cancer cases worldwide occur in Asia-Pacific countries.
   
• Furthermore, increasing demand for non-invasive diagnostic methods, along with the trend of personalized medicine, is supporting the rapid growth of this market.
   

China smart pills market is anticipated to witness lucrative growth between 2026 - 2035.
 

• The growing population, along with the increasing rate of chronic diseases and gastrointestinal disorders in the country, has increased the demand for innovative diagnostic technologies such as smart pills.
   
• Moreover, the rapid development of healthcare infrastructure as well as rising spending in healthcare technology in China has strengthened the adoption of smart pills.
   
• In addition, the government's efforts to promote digital health and improve healthcare access in the countryside are expected to further increase the market for smart pills in China.

Latin America Smart Pills Market

Brazil smart pills industry is anticipated to witness high growth in the Latin America market.
 

• Brazil dominated the Latin America market and accounted for the largest revenue share in 2025, attributed to growing incidence of chronic disorders and the demand for smart pills designed to administer medication at specific locations within the digestive system and to monitor vital signs, detect diseases, and provide real-time feedback.
   
• The country's growing emphasis on digital healthcare, along with the incorporation of Artificial Intelligence (AI) and the Internet of Things (IoT) in the healthcare sector, is enhancing the advancement and acceptance of smart pill technologies.
   

Middle East and Africa Smart Pills Market

South Africa market is anticipated to witness high growth in the Middle East and Africa market.
 

• Increasing healthcare spending and rising demand for advanced healthcare treatments are some of the factors further anticipated to boost the South Africa market during the forecast period.
   
• Moreover, increasing initiatives by market players to tap opportunities in the South Africa market, rising incidence of GI conditions, and strong distribution networks are a few of the key factors driving the market growth.
   

Smart Pills Market Share

The major players operating in the smart pills industry include Medtronic, Olympus Corporation, CapsoVision, IntroMedic, and Check‑Cap, among others. The top 3 players, including Medtronic, IntroMedic, and CapsoVision, account for over 55% of the global smart pills industry. These market players focus on strategies such as mergers, acquisitions, innovative product development and launches, expansion, and collaborations to generate more revenue and withstand market competition.
 

Moreover, businesses are allocating significant resources to research to accelerate innovation in this field. Additionally, there are several other emerging players operating in the market that strive for market share. These players are focusing their attention on emerging economies of the Asia Pacific and Latin America. 
 

Smart Pills Market Companies

Prominent players operating in the smart pill industry include:

• ANX Robotica
• Bodycap
• CapsoVision
• Check-Cap
• etectRx
• Intromedic
• Medtronic
• Otsuka Holdings
• Olympus Corporation
• RF Co.
   
• Medtronic

Medtronic leverages its expertise in medical technology to develop innovative ingestible devices. The company offers innovative PillCam technology. This ingestible capsule enables non-invasive imaging of the gastrointestinal tract, particularly the colon, aiding in the diagnosis of disorders such as colorectal cancer.
 

• Olympus Corporation

With its strong capabilities in medical imaging and endoscopy, Olympus stands as one of the key players in the smart pills industry. The company concentrates on creating next-generation capsule endoscopy systems to assist physicians in diagnosing and tracking gastrointestinal diseases with much less invasive techniques. The company's ENDOCAPSULE 10 SYSTEM produces extremely high-quality images for fast, efficient, and precise examinations of the small intestine.
 

Smart Pills Industry News

• In February 2023, AnX Robotica Corporation launched the NaviCam Small Bowel System in the U.S. This system allows complete, real-time visualization of the stomach using a pill-sized capsule containing a camera, and it is remote-controlled by the physician using proprietary magnetic technologies. This helped the company expand its reach to a broader patient population, increasing the potential market for the product.
   
• In February 2022, Check-Cap Ltd. announced that the company received approval from the U.S. Food and Drug Administration (FDA) for its amended Investigational Device Exemption (IDE) application, enabling initiation of the U.S. pivotal study.
   
• In January 2021, etectRx entered into an agreement with Pear Therapeutics, Inc. to develop up to two product candidates in the Central Nervous System (CNS) space combining Prescription Digital Therapeutics (PDTs) and adherence sensors. The companies aim to build products together, combining medication adherence data with digital therapeutics.
   
• In March 2017, BodyCap, a French MedTech company, obtained CE Mark approval for e-Celsius, an ingestible connected pill that monitors the body’s core temperature. This helped the company market its product in European countries and increase its sales.
   

The smart pills market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2022 - 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Component

• Product
  • Capsule
  • Other products
• Patient monitoring software

Market, By Target Area

• Stomach
• Small intestine
• Large intestine
• Esophagus

Market, By Application

• Capsule endoscopy
• Targeted drug delivery
• Vital sign monitoring

Market, By End Use

• Hospitals
• Diagnostic centers
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE